{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:19:42Z","timestamp":1783592382425,"version":"3.55.0"},"reference-count":47,"publisher":"Bioscientifica","issue":"10","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>SDHB, one of the four genes encoding the subunits of the Krebs cycle enzyme succinate dehydrogenase (SDH), acts as a tumor suppressor in several human cancers, including pheochromocytomas\/paragangliomas. Mutations in SDHB lead to a reduction or complete loss of enzymatic activity, linking SDHB to paraganglioma malignancy. Given the difficulty in curing metastatic paragangliomas and the limited value of surgery, new treatments are needed. Glutamine dehydrogenase 1 (GDH1), a key regulator of glutathione metabolism, and poly (ADP-ribose) polymerase (PARP), essential for repairing single- or double-stranded DNA breaks, are crucial in cancer initiation and progression. We treated the human pheochromocytoma cell line (hPheo1) with knocked-down SDHB using radiation, the GDH inhibitor \u2018R162\u2019, and the PARP inhibitor \u2018olaparib\u2019. Combining R162 with radiation enhances anticancer effectiveness, reduces cell proliferation, and causes G2\/M phase arrest in the wild-type and KD-SDHB hPheo1 cell line. KD-SDHB hPheo1 cells treated with olaparib alone were more resistant than wild-type cells but were more sensitive in combination with radiation, activated repair mechanisms, and halted cell cycle progression at the G2\/M phase. These results suggest that enhancing radiation-induced DNA damage could be a potential treatment strategy for metastatic pheochromocytomas\/paragangliomas. Inhibiting GDH1 and PARP activities, with radiation, may represent promising strategies for the treatment of SDHB-deficient pheochromocytoma\/paraganglioma; however, their effects do not appear to be specific to SDHB-deficient cells and require further validation.<\/jats:p>","DOI":"10.1530\/erc-25-0173","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T12:47:55Z","timestamp":1758718075000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":0,"title":["Role of GDH and PARP inhibitors as novel treatments for SDHB-deficient PPGLs"],"prefix":"10.1530","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2873-161X","authenticated-orcid":true,"given":"Mouna","family":"Tabebi","sequence":"first","affiliation":[{"name":"Department of Biomedical and Clinical Sciences (BKV), Link\u00f6ping University 1 , ,","place":["Linkoping, Sweden"]},{"name":"Clinical Genomics Link\u00f6ping, Science for Life Laboratory, Link\u00f6ping University 2 , ,","place":["Linkoping, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sallam","family":"Abdallah","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences (BKV), Link\u00f6ping University 1 , ,","place":["Linkoping, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"El-Serafi","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences (BKV), Link\u00f6ping University 1 , ,","place":["Linkoping, Sweden"]},{"name":"Department of Hand Surgery Plastic Surgery and Burns, Link\u00f6ping University Hospital 3 , ,","place":["Linkoping, Sweden"]},{"name":"College of Health Sciences and Research Institute for Medical and Health Sciences, University of Sharjah 4 , ,","place":["Sharjah, UAE"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"S\u00f6derkvist","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences (BKV), Link\u00f6ping University 1 , ,","place":["Linkoping, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Gimm","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences (BKV), Link\u00f6ping University 1 , ,","place":["Linkoping, Sweden"]},{"name":"Department of Surgery, Region \u00d6sterg\u00f6tland 5 , ,","place":["Link\u00f6ping, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"key":"2026070905410674400_bib1","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1002\/bjs.10744","article-title":"Extent of surgery for phaeochromocytomas in the genomic era","volume":"105","author":"Rossitti","year":"2018","journal-title":"Br J Surg"},{"key":"2026070905410674400_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"key":"2026070905410674400_bib3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.critrevonc.2016.01.022","article-title":"Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era","volume":"100","author":"Pillai","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026070905410674400_bib4","doi-asserted-by":"crossref","first-page":"R253","DOI":"10.1530\/ERC-11-0170","article-title":"Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas","volume":"18","author":"Welander","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"2026070905410674400_bib5","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-23-0061","article-title":"Genetic variants and down-regulation of CACNA1H in pheochromocytoma","volume":"31","author":"Svahn","year":"2024","journal-title":"Endocr Relat Cancer"},{"key":"2026070905410674400_bib6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3390\/ijms23010560","article-title":"Loss of SDHB induces a metabolic switch in the hPheo1 cell line toward enhanced OXPHOS","volume":"23","author":"Tabebi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026070905410674400_bib7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3390\/cancers12030599","article-title":"Glutaminases as a novel target for SDHB-associated pheochromocytomas\/paragangliomas","volume":"12","author":"Sarkadi","year":"2020","journal-title":"Cancers"},{"key":"2026070905410674400_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/EJE-17-0074","article-title":"The phenotype of SDHB germline mutation carriers: a nationwide study","volume":"177","author":"Niemeijer","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"2026070905410674400_bib9","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1073\/pnas.1009199108","article-title":"Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations","volume":"108","author":"Janeway","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070905410674400_bib10","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1096\/fj.12-210146","article-title":"Missense mutations in the human SDHB gene increase protein degradation without altering intrinsic enzymatic function","volume":"26","author":"Yang","year":"2012","journal-title":"FASEB J"},{"key":"2026070905410674400_bib11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1371\/journal.pgen.0010008","article-title":"A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas","volume":"1","author":"Dahia","year":"2005","journal-title":"PLoS Genet"},{"key":"2026070905410674400_bib12","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1038\/s41598-018-21361-6","article-title":"Decreased succinate dehydrogenase B in human hepatocellular carcinoma accelerates tumor malignancy by inducing the Warburg effect","volume":"8","author":"Tseng","year":"2018","journal-title":"Sci Rep"},{"key":"2026070905410674400_bib13","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.3390\/cancers13153769","article-title":"Reactive oxygen species: a promising therapeutic target for SDHx-mutated pheochromocytoma and paraganglioma","volume":"13","author":"Hadrava Vanova","year":"2021","journal-title":"Cancers"},{"key":"2026070905410674400_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12929-022-00878-z","article-title":"Cancer-derived extracellular succinate: a driver of cancer metastasis","volume":"29","author":"Kuo","year":"2022","journal-title":"J Biomed Sci"},{"key":"2026070905410674400_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase","volume":"7","author":"Selak","year":"2005","journal-title":"Cancer Cell"},{"key":"2026070905410674400_bib16","article-title":"Glutamate dehydrogenase (GDH) regulates bioenergetics and redox homeostasis in human glioma","volume":"5","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"2026070905410674400_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1143798","article-title":"Rethinking glutamine metabolism and the regulation of glutamine addiction by oncogenes in cancer","volume":"13","author":"Ni","year":"2023","journal-title":"Front Oncol"},{"key":"2026070905410674400_bib18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13046-024-02994-0","article-title":"A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle","volume":"43","author":"Wang","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"2026070905410674400_bib19","article-title":"Targeting glutaminolysis: new perspectives to understand cancer development and novel strategies for potential target therapies","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"key":"2026070905410674400_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2002810","article-title":"Glutamine deficiency induces DNA alkylation damage and sensitizes cancer cells to alkylating agents through inhibition of ALKBH enzymes","volume":"15","author":"Tran","year":"2017","journal-title":"PLoS Biol"},{"key":"2026070905410674400_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40170-015-0137-1","article-title":"Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by \u00df-lapachone","volume":"3","author":"Chakrabarti","year":"2015","journal-title":"Cancer Metabol"},{"key":"2026070905410674400_bib22","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s41588-018-0170-4","article-title":"Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair","volume":"50","author":"Sulkowski","year":"2018","journal-title":"Nat Genet"},{"key":"2026070905410674400_bib23","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1101\/gad.191056.112","article-title":"Inhibition of \u03b1-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors","volume":"26","author":"Xiao","year":"2012","journal-title":"Genes Dev"},{"key":"2026070905410674400_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.semradonc.2021.09.004","article-title":"Oncometabolites as regulators of DNA damage response and repair","volume":"32","author":"Gueble","year":"2022","journal-title":"Semin Radiat Oncol"},{"key":"2026070905410674400_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00432-018-2774-6","article-title":"PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines","volume":"145","author":"Camero","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"2026070905410674400_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bcp.2012.03.018","article-title":"The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art","volume":"84","author":"De Vos","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"2026070905410674400_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0300-483X(03)00291-9","article-title":"Homologous recombination and cell cycle checkpoints: Rad51 in tumour progression and therapy resistance","volume":"193","author":"Henning","year":"2003","journal-title":"Toxicology"},{"key":"2026070905410674400_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.564601","article-title":"PARP inhibitors: clinical relevance, mechanisms of action and tumor resistance","volume":"8","author":"Rose","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"2026070905410674400_bib29","doi-asserted-by":"crossref","first-page":"14565","DOI":"10.1074\/jbc.M110.104745","article-title":"Sensitivity to Poly(ADP-ribose) polymerase (PARP) inhibition identifies ubiquitin-specific peptidase 11 (USP11) as a regulator of DNA double-strand break repair","volume":"285","author":"Wiltshire","year":"2010","journal-title":"J Biol Chem"},{"key":"2026070905410674400_bib30","first-page":"115","volume-title":"DNA Repair in Cancer Therapy","author":"D\u2019Arcangelo","edition":"2nd edn"},{"key":"2026070905410674400_bib31","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78654","article-title":"Mitochondrial redox adaptations enable alternative aspartate synthesis in SDH-deficient cells","volume":"12","author":"Hart","year":"2023","journal-title":"ELife"},{"key":"2026070905410674400_bib32","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1158\/1078-0432.CCR-17-3406","article-title":"Targeting NAD+\/PARP DNA repair pathway as a novel therapeutic approach to SDHB-mutated cluster I pheochromocytoma and paraganglioma","volume":"24","author":"Pang","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2026070905410674400_bib33","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"key":"2026070905410674400_bib34","doi-asserted-by":"crossref","DOI":"10.1177\/1179064418761639","article-title":"The impact of radiation on the tumor microenvironment: effect of dose and fractionation schedules","volume":"11","author":"Arnold","year":"2018","journal-title":"Cancer Growth Metastasis"},{"key":"2026070905410674400_bib35","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"2026070905410674400_bib36","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1158\/0008-5472.CAN-04-3995","article-title":"Lost in transcription: p21 repression, mechanisms, and consequences","volume":"65","author":"Gartel","year":"2005","journal-title":"Cancer Res"},{"key":"2026070905410674400_bib37","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3390\/cancers11091220","article-title":"The multifaceted p21 (Cip1\/Waf1\/CDKN1A) in cell differentiation, migration and cancer therapy","volume":"11","author":"Kreis","year":"2019","journal-title":"Cancers"},{"key":"2026070905410674400_bib38","article-title":"SDHA-related phaeochromocytoma and paraganglioma: review and clinical management","volume":"31","author":"Kaplan","year":"2024","journal-title":"Endocr Relat Cancer"},{"key":"2026070905410674400_bib39","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/jmedgenet-2017-105127","article-title":"Tumour risks and genotype\u2013phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD","volume":"55","author":"Andrews","year":"2018","journal-title":"J Med Genet"},{"key":"2026070905410674400_bib40","doi-asserted-by":"crossref","first-page":"7530","DOI":"10.1038\/ncomms8530","article-title":"The cell cycle regulator 14-3-3\u03c3 opposes and reverses cancer metabolic reprogramming","volume":"6","author":"Phan","year":"2015","journal-title":"Nat Commun"},{"key":"2026070905410674400_bib41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ccell.2014.12.006","article-title":"Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth","volume":"27","author":"Jin","year":"2015","journal-title":"Cancer Cell"},{"key":"2026070905410674400_bib42","first-page":"1957","article-title":"Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction","volume":"9","author":"Wachsberger","year":"2003","journal-title":"Clin Cancer Res"},{"key":"2026070905410674400_bib43","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1039\/C9AN02464F","article-title":"Sensitive and selective monitoring of the DNA damage-induced intracellular p21 protein and unraveling the role of the p21 protein in DNA repair and cell apoptosis by surface plasmon resonance","volume":"145","author":"He","year":"2020","journal-title":"Analyst"},{"key":"2026070905410674400_bib44","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrc2657","article-title":"p21 in cancer: intricate networks and multiple activities","volume":"9","author":"Abbas","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"2026070905410674400_bib45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13059-024-03260-4","article-title":"Sequential drug treatment targeting cell cycle and cell fate regulatory programs blocks non-genetic cancer evolution in acute lymphoblastic leukemia","volume":"25","author":"Malyukova","year":"2024","journal-title":"Genome Biol"},{"key":"2026070905410674400_bib46","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1001\/jamaoncol.2022.5074","article-title":"Concurrent olaparib and radiotherapy in patients with triple-negative breast cancer","volume":"8","author":"Loap","year":"2022","journal-title":"JAMA Oncol"},{"key":"2026070905410674400_bib47","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1186\/s12885-016-2656-8","article-title":"An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma","volume":"16","author":"Nile","year":"2016","journal-title":"BMC Cancer"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/32\/10\/ERC-25-0173.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/32\/10\/ERC-25-0173.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0173\/144718\/erc-25-0173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0173\/144718\/erc-25-0173.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T09:41:16Z","timestamp":1783590076000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/32\/10\/e250173\/25873\/Role-of-GDH-and-PARP-inhibitors-as-novel"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1530\/erc-25-0173","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"article-number":"e250173"}}